Provided by Tiger Trade Technology Pte. Ltd.

IO Biotech, Inc.

0.4801
+0.2725131.26%
Pre-market: 0.4600-0.0201-4.19%04:53 EST
Volume:473.91M
Turnover:190.44M
Market Cap:34.54M
PE:-0.36
High:0.5792
Open:0.2464
Low:0.2302
Close:0.2076
52wk High:2.79
52wk Low:0.2053
Shares:71.95M
Float Shares:31.16M
Volume Ratio:61.50
T/O Rate:1520.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3356
EPS(LYR):-1.4494
ROE:-240.48%
ROA:-88.58%
PB:37.92
PE(LYR):-0.33

Loading ...

BRIEF-Io Biotech Announces Exploration Of Strategic Alternatives

Reuters
·
Jan 21

IO Biotech announces exploration of strategic alternatives

TIPRANKS
·
Jan 21

IO Biotech Announces Exploration of Strategic Alternatives

THOMSON REUTERS
·
Jan 21

IO Biotech Inc - Evaluating Further Reduction-in-Force to Cut Expenses

THOMSON REUTERS
·
Jan 21

Morgan Stanley Downgrades IO Biotech to Underweight, Price Target is $0.36

MT Newswires Live
·
Jan 08

IO Biotech Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance

Reuters
·
Dec 20, 2025

IO Biotech Reports Five-Year Survival Data for IO102-IO103 Vaccine in Metastatic Melanoma Trial

Reuters
·
Dec 16, 2025

IO Biotech Announces Publication of Five-Year Clinical Outcomes of Phase 1/2 Trial in Nature Communications

THOMSON REUTERS
·
Dec 16, 2025

IO Biotech Announces Participation in Upcoming December Investor Conferences

GlobeNewswire
·
Nov 26, 2025

IO Biotech Announces Resignation of Chief Accounting Officer

TIPRANKS
·
Nov 22, 2025

IO Biotech Appoints CFO Amy Sullivan as Principal Accounting Officer

Reuters
·
Nov 22, 2025

IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Reuters
·
Nov 20, 2025

Piper Sandler Sticks to Its Buy Rating for IO Biotech (IOBT)

TIPRANKS
·
Nov 19, 2025

IO Biotech Presents at Jefferies Global Healthcare Conference

TIPRANKS
·
Nov 18, 2025

IO Biotech’s Hold Rating Amid Financial and Regulatory Uncertainty

TIPRANKS
·
Nov 16, 2025

Analysts Are Neutral on Top Healthcare Stocks: Anavex Life Sciences (AVXL), IO Biotech (IOBT)

TIPRANKS
·
Nov 15, 2025

IO Biotech reports $8.4 mln Q3 net loss

Reuters
·
Nov 14, 2025

IO Biotech Q3 EPS $(0.13) Beats $(0.34) Estimate

Benzinga
·
Nov 14, 2025

IO Biotech Q3 Operating Income USD -19.355 Million

THOMSON REUTERS
·
Nov 14, 2025

IO Biotech Q3 Pretax Profit USD -10.042 Million

THOMSON REUTERS
·
Nov 14, 2025